Northern Trust’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-46,072
Closed -$58.7K 4623
2023
Q3
$58.7K Sell
46,072
-69,138
-60% -$88.2K ﹤0.01% 4131
2023
Q2
$37.6K Hold
115,210
﹤0.01% 4284
2023
Q1
$49.5K Sell
115,210
-1,547
-1% -$665 ﹤0.01% 4272
2022
Q4
$61.9K Hold
116,757
﹤0.01% 4228
2022
Q3
$85K Buy
116,757
+1,775
+2% +$1.29K ﹤0.01% 4164
2022
Q2
$131K Sell
114,982
-227
-0.2% -$259 ﹤0.01% 4069
2022
Q1
$236K Sell
115,209
-5,260
-4% -$10.8K ﹤0.01% 4062
2021
Q4
$347K Sell
120,469
-17,235
-13% -$49.6K ﹤0.01% 3950
2021
Q3
$584K Buy
137,704
+16,960
+14% +$71.9K ﹤0.01% 3712
2021
Q2
$639K Buy
120,744
+21,060
+21% +$111K ﹤0.01% 3637
2021
Q1
$463K Sell
99,684
-25,052
-20% -$116K ﹤0.01% 3836
2020
Q4
$412K Sell
124,736
-14,123
-10% -$46.6K ﹤0.01% 3771
2020
Q3
$460K Buy
138,859
+4,885
+4% +$16.2K ﹤0.01% 3638
2020
Q2
$451K Sell
133,974
-195,407
-59% -$658K ﹤0.01% 3579
2020
Q1
$1.26M Buy
329,381
+13,307
+4% +$50.9K ﹤0.01% 3105
2019
Q4
$1.91M Buy
316,074
+999
+0.3% +$6.03K ﹤0.01% 3151
2019
Q3
$2.38M Buy
315,075
+215,577
+217% +$1.63M ﹤0.01% 3005
2019
Q2
$1.35M Buy
99,498
+26,502
+36% +$359K ﹤0.01% 3254
2019
Q1
$395K Sell
72,996
-13,959
-16% -$75.5K ﹤0.01% 3597
2018
Q4
$258K Sell
86,955
-8,247
-9% -$24.5K ﹤0.01% 3725
2018
Q3
$776K Buy
95,202
+32,461
+52% +$265K ﹤0.01% 3536
2018
Q2
$612K Sell
62,741
-104,601
-63% -$1.02M ﹤0.01% 3556
2018
Q1
$1.46M Buy
167,342
+24,663
+17% +$214K ﹤0.01% 3261
2017
Q4
$1.79M Buy
142,679
+6,787
+5% +$85K ﹤0.01% 3199
2017
Q3
$1.14M Buy
135,892
+16
+0% +$134 ﹤0.01% 3405
2017
Q2
$2.31M Buy
135,876
+109,770
+420% +$1.86M ﹤0.01% 3094
2017
Q1
$525K Buy
26,106
+1,859
+8% +$37.4K ﹤0.01% 3519
2016
Q4
$378K Buy
24,247
+1,468
+6% +$22.9K ﹤0.01% 3595
2016
Q3
$297K Buy
+22,779
New +$297K ﹤0.01% 3627
2016
Q2
Sell
-33,919
Closed -$321K 4287
2016
Q1
$321K Hold
33,919
﹤0.01% 3575
2015
Q4
$342K Buy
+33,919
New +$342K ﹤0.01% 3595